1. Home
  2. CGNX vs NUVL Comparison

CGNX vs NUVL Comparison

Compare CGNX & NUVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cognex Corporation

CGNX

Cognex Corporation

HOLD

Current Price

$53.97

Market Cap

7.9B

Sector

Industrials

ML Signal

HOLD

Logo Nuvalent Inc.

NUVL

Nuvalent Inc.

HOLD

Current Price

$101.65

Market Cap

8.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CGNX
NUVL
Founded
1981
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.9B
8.3B
IPO Year
1994
2021

Fundamental Metrics

Financial Performance
Metric
CGNX
NUVL
Price
$53.97
$101.65
Analyst Decision
Buy
Strong Buy
Analyst Count
11
16
Target Price
$57.91
$134.75
AVG Volume (30 Days)
1.5M
600.6K
Earning Date
05-06-2026
05-08-2026
Dividend Yield
0.62%
N/A
EPS Growth
9.68
N/A
EPS
0.68
N/A
Revenue
N/A
N/A
Revenue This Year
$9.52
N/A
Revenue Next Year
$8.63
$1,239.49
P/E Ratio
$80.72
N/A
Revenue Growth
N/A
N/A
52 Week Low
$26.14
$63.56
52 Week High
$59.88
$113.02

Technical Indicators

Market Signals
Indicator
CGNX
NUVL
Relative Strength Index (RSI) 54.83 44.73
Support Level $40.76 $97.94
Resistance Level $59.11 $107.08
Average True Range (ATR) 1.74 3.51
MACD -0.07 -0.36
Stochastic Oscillator 28.62 19.14

Price Performance

Historical Comparison
CGNX
NUVL

About CGNX Cognex Corporation

Cognex Corp provides machine vision products that help automate manufacturing processes. The firm's products include vision software, vision systems, vision sensors, and ID products. Vision software combines vision tools with a customer's cameras and peripheral equipment and can help with several vision tasks, including part location, identification, measurement, and robotic guidance. Vision systems combine a camera, processor, and vision software into a single package. Vision sensors deliver simple, low-cost solutions for common vision applications, such as checking the size of parts. Geographically, it operates in United states, Europe, Greater China and others. Cognex generates the maximum proportion of its sales in the United States and Europe.

About NUVL Nuvalent Inc.

Nuvalent Inc is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer. All of its operations are in the United States. The company is engaged in developing small molecules that are designed to overcome the limitations of existing therapies for clinically validated kinase targets. The product candidates of the company include NVL-520, which is being developed for patients with ROS1-positive non-small cell lung cancer (NSCLC), NVL-655, which is being developed for patients with anaplastic lymphoma kinase (ALK)-positive NSCLC, NVL-330, is a brain-penetrant human epidermal growth factor receptor 2 (HER2)-selective inhibitor designed to address the combined medical need of treating tumors driven by HER2ex20.

Share on Social Networks: